Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2455-2468

  Banda, Nirmal K ^a   Mehta, Gaurav ^a   Kjaer, Troels R ^b   Takahashi, Minoru ^c   Schaack, Jerome ^a   Morrison, Thomas E ^a   Thiel, Steffen ^b   Arend, William P ^a   Holers, Michael V ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT INHIBITOR; GREEN FLUORESCENT PROTEIN; PROTEIN MAP44; UNCLASSIFIED DRUG; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MASP-1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE INJURY; CARTILAGE INJURY; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DOSE RESPONSE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MALE; MOUSE; NONHUMAN; PANNUS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; ROSS RIVER ALPHA VIRUS; ADENOVIRIDAE; ALPHAVIRUS INFECTION; ALTERNATIVE RNA SPLICING; ANIMAL; EXPERIMENTAL ARTHRITIS; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY;

ADENOVIRIDAE; ALPHAVIRUS INFECTIONS; ALTERNATIVE SPLICING; ANIMALS; ARTHRITIS, EXPERIMENTAL; COMPLEMENT C3; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; HUMANS; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MICE; MICE, KNOCKOUT; ROSS RIVER VIRUS; TRANSDUCTION, GENETIC;

EID: 84907033609     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400752     Document Type: Article

References (62)

1. Helmick, C. G., D. T. Felson, R. C. Lawrence, S. Gabriel, R. Hirsch, C. K. Kwoh, M. H. Liang, H. M. Kremers, M. D. Mayes, P. A. Merkel, et al; National Arthritis Data Workgroup. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58: 15-25.
2. Arend, W. P., and G. S. Firestein. 2012. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat. Rev. Rheumatol. 8: 573-586.
3. Klareskog, L., J. Rönnelid, K. Lundberg, L. Padyukov, and L. Alfredsson. 2008. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26: 651-675.
4. Banda, N. K., J. M. Thurman, D. Kraus, A. Wood, M. C. Carroll, W. P. Arend, and V. M. Holers. 2006. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collageninduced arthritis. J. Immunol. 177: 1904-1912.
5. Hietala, M. A., I. M. Jonsson, A. Tarkowski, S. Kleinau, and M. Pekna. 2002. Complement deficiency ameliorates collagen-induced arthritis in mice. J. Immunol. 169: 454-459.
6. Ji, H., K. Ohmura, U. Mahmood, D. M. Lee, F. M. Hofhuis, S. A. Boackle, K. Takahashi, V. M. Holers, M. Walport, C. Gerard, et al. 2002. Arthritis critically dependent on innate immune system players. Immunity 16: 157-168.
7. Wang, Y., J. Kristan, L. Hao, C. S. Lenkoski, Y. Shen, and L. A. Matis. 2000. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J. Immunol. 164: 4340-4347.
8. Okroj, M., D. Heinegård, R. Holmdahl, and A. M. Blom. 2007. Rheumatoid arthritis and the complement system. Ann. Med. 39: 517-530.
9. Sturfelt, G., and L. Truedsson. 2012. Complement in the immunopathogenesis of rheumatic disease. Nat. Rev. Rheumatol. 8: 458-468.
10. Zvaifler, N. J. 1974. Rheumatoid synovitis. An extravascular immune complex disease. Arthritis Rheum. 17: 297-305.
11. Cooke, T. D., E. R. Hurd, H. E. Jasin, J. Bienenstock, and M. Ziff. 1975. Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum. 18: 541-551.
12. Ghose, T., J. F. Woodbury, S. Ahmad, and B. Stevenson. 1975. Immunopathological changes in rheumatoid arthritis and other joint diseases. J. Clin. Pathol. 28: 109-117.
13. Ohno, O., and T. D. Cooke. 1978. Electron microscopic morphology of immunoglobulin aggregates and their interactions in rheumatoid articular collagenous tissues. Arthritis Rheum. 21: 516-527.
14. Banda, N. K., A. K. Wood, K. Takahashi, B. Levitt, P. M. Rudd, L. Royle, J. L. Abrahams, G. L. Stahl, V. M. Holers, and W. P. Arend. 2008. Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. Arthritis Rheum. 58: 3081-3089.
15. Ratnoff, W. D., D. T. Fearon, and K. F. Austen. 1983. The role of antibody in the activation of the alternative complement pathway. Springer Semin. Immunopathol. 6: 361-371.
16. Wouters, D., A. E. Voskuyl, E. T. Molenaar, B. A. Dijkmans, and C. E. Hack. 2006. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. Arthritis Rheum. 54: 1143-1150.
17. Banda, N. K., K. Takahashi, A. K. Wood, V. M. Holers, and W. P. Arend. 2007. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J. Immunol. 179: 4101-4109.
18. Hansen, S., S. Thiel, A. Willis, U. Holmskov, and J. C. Jensenius. 2000. Purification and characterization of two mannan-binding lectins from mouse serum. J. Immunol. 164: 2610-2618.
19. Kawai, T., Y. Suzuki, S. Eda, T. Kase, K. Ohtani, Y. Sakai, H. Keshi, A. Fukuoh, T. Sakamoto, M. Nozaki, et al. 2002. Molecular cloning of mouse collectin liver 1. Biosci. Biotechnol. Biochem. 66: 2134-2145.
20. Ohashi, T., and H. P. Erickson. 1998. Oligomeric structure and tissue distribution of ficolins from mouse, pig and human. Arch. Biochem. Biophys. 360: 223-232.
21. Ohtani, K., Y. Suzuki, S. Eda, T. Kawai, T. Kase, H. Yamazaki, T. Shimada, H. Keshi, Y. Sakai, A. Fukuoh, et al. 1999. Molecular cloning of a novel human collectin from liver (CL-L1). J. Biol. Chem. 274: 13681-13689.
22. Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, et al. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386: 506-510.
23. Møller-Kristensen, M., S. Thiel, A. Sjöholm, M. Matsushita, and J. C. Jensenius. 2007. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int. Immunol. 19: 141-149.
24. Héja, D., A. Kocsis, J. Dobó, K. Szilágyi, R. Szász, P. Závodszky, G. Pál, and P. Gál. 2012. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc. Natl. Acad. Sci. USA 109: 10498-10503.
25. Pangburn, M. K., R. D. Schreiber, and H. J. Müller-Eberhard. 1983. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J. Immunol. 131: 1930-1935.
26. Rosen, B. S., K. S. Cook, J. Yaglom, D. L. Groves, J. E. Volanakis, D. Damm, T. White, and B. M. Spiegelman. 1989. Adipsin and complement factor D activity: an immune-related defect in obesity. Science 244: 1483-1487.
27. Kemper, C., J. P. Atkinson, and D. E. Hourcade. 2010. Properdin: emerging roles of a pattern-recognition molecule. Annu. Rev. Immunol. 28: 131-155.
28. Hiemstra, P. S., J. Biewenga, A. Gorter, M. E. Stuurman, A. Faber, L. A. van Es, and M. R. Daha. 1988. Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. Mol. Immunol. 25: 527-533.
29. Takahashi, M., Y. Ishida, D. Iwaki, K. Kanno, T. Suzuki, Y. Endo, Y. Homma, and T. Fujita. 2010. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J. Exp. Med. 207: 29-37.
30. Takahashi, M., D. Iwaki, K. Kanno, Y. Ishida, J. Xiong, M. Matsushita, Y. Endo, S. Miura, N. Ishii, K. Sugamura, and T. Fujita. 2008. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J. Immunol. 180: 6132-6138.
31. Ruseva, M. M., M. Takahashi, T. Fujita, and M. C. Pickering. 2013. C3 dysregulation due to factor H deficiency is MASP-1 and MASP-3 independent in vivo. Clin. Exp. Immunol. 176: 84-92.
32. Degn, S. E., L. Jensen, A. G. Hansen, D. Duman, M. Tekin, J. C. Jensenius, and S. Thiel. 2012. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J. Immunol. 189: 3957-3969.
33. Degn, S. E., L. Jensen, P. Gál, J. Dobó, S. H. Holmvad, J. C. Jensenius, and S. Thiel. 2010. Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system. J. Immunol. Methods 361: 37-50.
34. Skjoedt, M. O., T. Hummelshoj, Y. Palarasah, C. Honore, C. Koch, K. Skjodt, and P. Garred. 2010. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J. Biol. Chem. 285: 8234-8243.
35. Dahl, M. R., S. Thiel, M. Matsushita, T. Fujita, A. C. Willis, T. Christensen, T. Vorup-Jensen, and J. C. Jensenius. 2001. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15: 127-135.
36. Degn, S. E., A. G. Hansen, R. Steffensen, C. Jacobsen, J. C. Jensenius, and S. Thiel. 2009. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J. Immunol. 183: 7371-7378.
37. Pavlov, V. I., M. O. Skjoedt, Y. Siow Tan, A. Rosbjerg, P. Garred, and G. L. Stahl. 2012. Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis. Circulation 126: 2227-2235.
38. Banda, N. K., M. Takahashi, B. Levitt, M. Glogowska, J. Nicholas, K. Takahashi, G. L. Stahl, T. Fujita, W. P. Arend, and V. M. Holers. 2010. Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis. J. Immunol. 185: 5598-5606.
39. Matsushita, M., and T. Fujita. 1995. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation. Immunobiology 194: 443-448.
40. Bakker, A. C., F. A. Van de Loo, L. A. Joosten, M. B. Bennink, O. J. Arntz, I. P. Dmitriev, E. A. Kashentsera, D. T. Curiel, and W. B. van den Berg. 2001. A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis. Gene Ther. 8: 1785-1793.
41. Morrison, T. E., R. J. Fraser, P. N. Smith, S. Mahalingam, and M. T. Heise. 2007. Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J. Virol. 81: 5132-5143.
42. Morrison, T. E., J. D. Simmons, and M. T. Heise. 2008. Complement receptor 3 promotes severe ross river virus-induced disease. J. Virol. 82: 11263-11272.
43. Morrison, T. E., A. C.Whitmore, R. S. Shabman, B. A. Lidbury, S. Mahalingam, and M. T. Heise. 2006. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J. Virol. 80: 737-749.
44. Banda, N. K., B. Levitt, A. K. Wood, K. Takahashi, G. L. Stahl, V. M. Holers, and W. P. Arend. 2010. Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro. Clin. Exp. Immunol. 159: 100-108.
45. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3: 1101-1108.
46. Banda, N. K., S. Hyatt, A. H. Antonioli, J. T. White, M. Glogowska, K. Takahashi, T. J. Merkel, G. L. Stahl, S. Mueller-Ortiz, R. Wetsel, et al. 2012. Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice. J. Immunol. 188: 1469-1478.
47. Banda, N. K., and K. Takahashi. 2014. Analysis of the complement activation in mice. Methods Mol. Biol. 1100: 365-371.
48. Kimura, Y., T. Miwa, L. Zhou, and W. C. Song. 2008. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111: 732-740.
49. Presanis, J. S., K. Hajela, G. Ambrus, P. Gál, and R. B. Sim. 2004. Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol. Immunol. 40: 921-929.
50. Degn, S. E., L. Jensen, T. Olszowski, J. C. Jensenius, and S. Thiel. 2013. Cocomplexes of MASP-1 and MASP-2 associated with the soluble patternrecognition molecules drive lectin pathway activation in a manner inhibitable by MAp44. J. Immunol. 191: 1334-1345.
51. Takahashi, M., H. Sekine, Y. Endo, and T. Fujita. 2013. Comment on "Mannanbinding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function". J. Immunol. 190: 2477.
52. Takahashi, M., H. Sekine, and T. Fujita. 2014. Comment on "The Pro-Factor D Cleaving Activity of MASP-1/-3 Is Not Required for Alternative Pathway Function". J. Immunol. 192: 5448-5449.
53. Bai, M., B. Harfe, and P. Freimuth. 1993. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cellrounding activity and delay virus reproduction in flat cells. J. Virol. 67: 5198-5205.
54. Mathias, P., T. Wickham, M. Moore, and G. Nemerow. 1994. Multiple adenovirus serotypes use alpha v integrins for infection. J. Virol. 68: 6811-6814.
55. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
56. Nikkari, L., K. Haapasalmi, H. Aho, A. Torvinen, D. Sheppard, H. Larjava, and J. Heino. 1995. Localization of the alpha v subfamily of integrins and their putative ligands in synovial lining cell layer. J. Rheumatol. 22: 16-23.
57. Pirilä, L., and J. Heino. 1996. Altered integrin expression in rheumatoid synovial lining type B cells: in vitro cytokine regulation of alpha 1 beta 1, alpha 6 beta 1, and alpha v beta 5 integrins. J. Rheumatol. 23: 1691-1698.
58. Rinaldi, N., D. Weis, B. Brado, M. Schwarz-Eywill, M. Lukoschek, A. Pezzutto, U. Keilholz, and T. F. Barth. 1997. Differential expression and functional behaviour of the alpha v and beta 3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro. Ann. Rheum. Dis. 56: 729-736.
59. Ebina, K., K. Oshima, M. Matsuda, A. Fukuhara, K. Maeda, S. Kihara, J. Hashimoto, T. Ochi, N. K. Banda, H. Yoshikawa, and I. Shimomura. 2009. Adenovirus-mediated gene transfer of adiponectin reduces the severity of collagen-induced arthritis in mice. Biochem. Biophys. Res. Commun. 378: 186-191.
60. Iwaki, D., K. Kanno, M. Takahashi, Y. Endo, M. Matsushita, and T. Fujita. 2011. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway. J. Immunol. 187: 3751-3758.
61. Wilson, J. M. 1996. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334: 1185-1187.
62. Toh, M. L., S. S. Hong, F. van de Loo, L. Franqueville, L. Lindholm, W. van den Berg, P. Boulanger, and P. Miossec. 2005. Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)-and non-RGDbinding integrins. J. Immunol. 175: 7687-7698.